|
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RECRUITINGSponsored by UroGen Pharma Ltd.
Actively Recruiting
SponsorUroGen Pharma Ltd.
Started2023-11-17
Est. completion2026-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations22 sites
View on ClinicalTrials.gov →
NCT05874921
Summary
The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Adults \>18 years old and capable of giving informed consent. * Diagnosis of UTUC. * Receipt of at least 1 dose of JELMYTO after FDA approval (15 Apr 2020). Exclusion Criteria: * Incapable of giving informed consent (e.g., incarcerated individuals, individuals with dementia). * Receipt of 1 or more doses of JELMYTO (also referred to as UGN-101 or Mitogel in clinical development) before FDA approval (on or before 15 Apr 2020). * Pregnancy or lactation. * Unable to comply with protocol requirements (for prospective data capture). * Any medical or mental condition(s) that makes participation in the Registry inadvisable in the opinion of the Investigator (for prospective data capture).
Conditions9
CancerCarcinoma, Transitional CellTransitional Cell Carcinoma of Renal PelvisUrothelial Cancer of Renal PelvisUrothelial CarcinomaUrothelial Carcinoma RecurrentUrothelial Carcinoma UreterUrothelial Carcinoma Ureter RecurrentUrothelial Carcinoma of the Renal Pelvis and Ureter
Locations22 sites
Providence St. Johns Health Center
Santa Monica, California, 90404
Jennifer Linehan, MDJennifer.linehan@providence.org
University of Florida
Gainesville, Florida, 32610
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Tampa, Florida, 33612
Wade Sexton, MDWade.Sexton@moffitt.org
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorUroGen Pharma Ltd.
Started2023-11-17
Est. completion2026-04
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations22 sites
View on ClinicalTrials.gov →
NCT05874921